Gullivers Flea & Tick Collar for dogs

Land: Irland

Språk: engelska

Källa: HPRA (Health Products Regulatory Authority)

Aktiva substanser:

Dimpylate

Tillgänglig från:

Chanelle Pharmaceuticals Manufacturing Limited

ATC-kod:

QP53AF03

INN (International namn):

Dimpylate

Dos:

3.9 gram(s)/collar

Läkemedelsform:

Medicated collar

Receptbelagda typ:

CAM: Companion Animal Medicine as defined in relevant national legislation

Terapeutisk grupp:

Canine

Terapiområde:

dimpylate

Terapeutiska indikationer:

Ectoparasiticide

Bemyndigande status:

Authorised

Tillstånd datum:

1989-10-01

Produktens egenskaper

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Gullivers Flea & Tick Collar for dogs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Per collar:
ACTIVE SUBSTANCE:
Dimpylate (as stabilized diazinon at 92% diazinon)
3.9 g
EXCIPIENTS:
Carbon black (E153)
0.004 g
For a full list of excipeints, see section 6.1
3 PHARMACEUTICAL FORM
Collar.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of infestation of dogs with fleas (Ctenocephalides
felis) and ticks (Ixodes ricinus).
4.3 CONTRAINDICATIONS
Do not use in case of known hypersensitivity to the active ingredient.
Do not use on sick and recovering dogs.
Do not use in dogs with known liver disorder.
Do not use in pregnant bitches.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
I
R
I
S
H
M
E
D
I
C
I
N
E
S
B
O
A
R
D
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_5_
_/_
_0_
_2_
_/_
_2_
_0_
_1_
_1_
_C_
_R_
_N_
_ _
_7_
_0_
_0_
_5_
_9_
_9_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
PRODUCT TO ANIMALS
Due to the potential risk of hypersensitivity developing in humans to
dimpylate, unnecessary handling of this product
should be avoided.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
An intoxication typical for organophosphorus compounds occurs rarely.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
Use during pregnancy is not recommended.
4.8 INT